ARCHIVES

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 30 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

New Agents, New Approaches Benefit Treatment Of Advanced Lung Cancer

August 29, 2003

NCI Faces $32 Million Budget Cut In FY 2006; NIH Tells Grantees To Expect 2.35 Percent Reduction In Award Funds.

January 13, 2006

Learning From Europeans, U.S. Oncologists Consider Role For Oxaliplatin, 5-FU Infusion

May 31, 2002

B-27 Finds Improved CR For Taxotere Prior To Surgery

November 28, 2003

Also in this 12-page issue: Senate report endorses NCI’s 2015 goal.

July 22, 2005

Harold Rusch, McArdle Gounder, Dies At 79

June 3, 1988